Pender Fund Capital Management Ltd. Accelerate Diagnostics, Inc Transaction History

Pender Fund Capital Management Ltd.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 16, 2022	SELL	$4.27 - $6.97 $1.99 Million - $3.24 Million	-465,259 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $2.47 Million - $3.84 Million	465,259 New	465,259 $3.44 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $113M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Pender Fund Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Pender Fund Capital Management Ltd. with notifications on news.